Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

This executive order amends a previous action by doubling tariffs on Chinese goods in response to China's failure to curb the flow of synthetic opioids like fentanyl into the United States. The order raises existing tariffs from 10% to 20% on products originating from China, citing the ongoing drug crisis as an "unusual and extraordinary threat" to U.S. national security and the economy. This action uses trade policy as leverage to pressure China into taking stronger enforcement measures against drug trafficking.